Filing Details
- Accession Number:
- 0001209191-20-010544
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-19 16:35:04
- Reporting Period:
- 2020-02-17
- Accepted Time:
- 2020-02-19 16:35:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242825 | M Jeffrey Leiden | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-17 | 9,314 | $241.50 | 123,226 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-02-18 | 1,680 | $241.78 | 121,546 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 4,241 | $242.61 | 117,305 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 1,971 | $243.65 | 115,334 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 2,030 | $244.87 | 113,304 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 1,763 | $245.66 | 111,541 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 440 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $241.78 (range $241.20 to $242.19).
- Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $242.61 (range $242.23 to $243.19).
- Open market sales reported on this line occurred at a weighted average price of $243.65 (range $243.24 to $244.23).
- Open market sales reported on this line occurred at a weighted average price of $244.87 (range $244.30 to $245.26).
- Open market sales reported on this line occurred at a weighted average price of $245.66 (range $245.32 to $245.92).
Billionaire Hedge Funds
